QQQ   444.85 (+0.00%)
AAPL   171.95 (-0.78%)
MSFT   420.96 (-0.11%)
META   488.82 (-1.02%)
GOOGL   151.19 (+0.21%)
AMZN   180.50 (+0.37%)
TSLA   176.03 (-2.11%)
NVDA   905.28 (+0.31%)
NIO   4.51 (-3.43%)
AMD   180.38 (+0.44%)
BABA   72.43 (+1.17%)
T   17.64 (+0.51%)
F   13.24 (+1.38%)
MU   117.94 (-1.01%)
CGC   8.41 (-11.94%)
GE   175.39 (-2.63%)
DIS   122.28 (+1.07%)
AMC   3.65 (-15.90%)
PFE   27.84 (+0.22%)
PYPL   67.26 (+1.04%)
XOM   116.07 (+0.96%)
QQQ   444.85 (+0.00%)
AAPL   171.95 (-0.78%)
MSFT   420.96 (-0.11%)
META   488.82 (-1.02%)
GOOGL   151.19 (+0.21%)
AMZN   180.50 (+0.37%)
TSLA   176.03 (-2.11%)
NVDA   905.28 (+0.31%)
NIO   4.51 (-3.43%)
AMD   180.38 (+0.44%)
BABA   72.43 (+1.17%)
T   17.64 (+0.51%)
F   13.24 (+1.38%)
MU   117.94 (-1.01%)
CGC   8.41 (-11.94%)
GE   175.39 (-2.63%)
DIS   122.28 (+1.07%)
AMC   3.65 (-15.90%)
PFE   27.84 (+0.22%)
PYPL   67.26 (+1.04%)
XOM   116.07 (+0.96%)
QQQ   444.85 (+0.00%)
AAPL   171.95 (-0.78%)
MSFT   420.96 (-0.11%)
META   488.82 (-1.02%)
GOOGL   151.19 (+0.21%)
AMZN   180.50 (+0.37%)
TSLA   176.03 (-2.11%)
NVDA   905.28 (+0.31%)
NIO   4.51 (-3.43%)
AMD   180.38 (+0.44%)
BABA   72.43 (+1.17%)
T   17.64 (+0.51%)
F   13.24 (+1.38%)
MU   117.94 (-1.01%)
CGC   8.41 (-11.94%)
GE   175.39 (-2.63%)
DIS   122.28 (+1.07%)
AMC   3.65 (-15.90%)
PFE   27.84 (+0.22%)
PYPL   67.26 (+1.04%)
XOM   116.07 (+0.96%)
QQQ   444.85 (+0.00%)
AAPL   171.95 (-0.78%)
MSFT   420.96 (-0.11%)
META   488.82 (-1.02%)
GOOGL   151.19 (+0.21%)
AMZN   180.50 (+0.37%)
TSLA   176.03 (-2.11%)
NVDA   905.28 (+0.31%)
NIO   4.51 (-3.43%)
AMD   180.38 (+0.44%)
BABA   72.43 (+1.17%)
T   17.64 (+0.51%)
F   13.24 (+1.38%)
MU   117.94 (-1.01%)
CGC   8.41 (-11.94%)
GE   175.39 (-2.63%)
DIS   122.28 (+1.07%)
AMC   3.65 (-15.90%)
PFE   27.84 (+0.22%)
PYPL   67.26 (+1.04%)
XOM   116.07 (+0.96%)
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

$26.25
-2.63 (-9.11%)
(As of 03:15 PM ET)
Today's Range
$24.24
$27.40
50-Day Range
$19.70
$32.15
52-Week Range
$15.10
$39.05
Volume
4.73 million shs
Average Volume
2.00 million shs
Market Capitalization
$3.90 billion
P/E Ratio
N/A
Dividend Yield
3.81%
Price Target
$28.22

Chemours MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
3.5% Upside
$28.22 Price Target
Short Interest
Healthy
3.33% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.10mentions of Chemours in the last 14 days
Based on 42 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
17.85%
From $2.97 to $3.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.58 out of 5 stars

Basic Materials Sector

133rd out of 171 stocks

Chemicals & Allied Products Industry

11th out of 14 stocks

CC stock logo

About Chemours Stock (NYSE:CC)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CC Stock Price History

CC Stock News Headlines

AI to Meet the Same Fate as EVs?
When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11…
Why Chemours Stock Is Plunging Today
AI to Meet the Same Fate as EVs?
When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11…
Chemours fourth-quarter loss narrows
Chemours (CC) Scheduled to Post Quarterly Earnings on Thursday
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/28/2023
Ex-Dividend for 3/15 Dividend
2/23/2024
Dividend Payable
3/15/2024
Today
3/28/2024
Next Earnings (Estimated)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$28.22
High Stock Price Target
$40.00
Low Stock Price Target
$19.00
Potential Upside/Downside
+4.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
8 Analysts

Profitability

Net Income
$578 million
Pretax Margin
-5.10%

Debt

Sales & Book Value

Annual Sales
$6.79 billion
Cash Flow
$6.79 per share
Book Value
$7.34 per share

Miscellaneous

Free Float
146,018,000
Market Cap
$4.01 billion
Optionable
Optionable
Beta
1.97
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

CC Stock Analysis - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price target for 2024?

8 brokerages have issued 12-month price targets for Chemours' shares. Their CC share price targets range from $19.00 to $40.00. On average, they anticipate the company's share price to reach $28.22 in the next year. This suggests a possible upside of 3.5% from the stock's current price.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2024?

Chemours' stock was trading at $31.54 at the start of the year. Since then, CC stock has decreased by 13.6% and is now trading at $27.26.
View the best growth stocks for 2024 here
.

Are investors shorting Chemours?

Chemours saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 4,640,000 shares, a decline of 5.9% from the January 31st total of 4,930,000 shares. Based on an average daily volume of 1,170,000 shares, the short-interest ratio is presently 4.0 days. Currently, 3.2% of the company's stock are sold short.
View Chemours' Short Interest
.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our CC earnings forecast
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) announced its earnings results on Friday, July, 28th. The specialty chemicals company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.09 by $0.01. The specialty chemicals company earned $1.64 billion during the quarter, compared to analyst estimates of $1.75 billion. Chemours had a positive trailing twelve-month return on equity of 42.13% and a negative net margin of 5.13%. During the same period last year, the firm posted $1.89 EPS.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Monday, February 12th. Shareholders of record on Monday, February 26th will be given a dividend of $0.25 per share on Friday, March 15th. This represents a $1.00 dividend on an annualized basis and a yield of 3.67%. The ex-dividend date of this dividend is Friday, February 23rd.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.65%.
Read our dividend analysis for CC.

What guidance has Chemours issued on next quarter's earnings?

Chemours issued an update on its FY 2023 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.0 billion-$6.0 billion, compared to the consensus revenue estimate of $6.0 billion.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

Who are Chemours' major shareholders?

Chemours' stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.80%), Vanguard Group Inc. (10.80%), Massachusetts Financial Services Co. MA (3.21%), Dimensional Fund Advisors LP (1.72%), LSV Asset Management (1.59%) and Vaughan Nelson Investment Management L.P. (0.93%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners